Magnus Financial Group’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.6K Hold
12,000
﹤0.01% 390
2026
Q1
$43.3K Hold
12,000
﹤0.01% 370
2025
Q4
$40.9K Buy
+12,000
New +$58.2K ﹤0.01% 413
2025
Q3
Sell
-16,000
Closed -$218K 410
2025
Q2
$218K Buy
+16,000
New +$151K 0.02% 353
2025
Q1
Sell
-16,000
Closed -$79.2K 384
2024
Q4
$79.2K Buy
16,000
+3,792
+31% +$19.9K 0.01% 356
2024
Q3
$64K Sell
12,208
-3,000
-20% -$17.3K 0.01% 337
2024
Q2
$104K Sell
15,208
-15,000
-50% -$137K 0.01% 312
2024
Q1
$311K Buy
30,208
+14,250
+89% +$105K 0.04% 242
2023
Q4
$132K Buy
15,958
+1,500
+10% +$10.8K 0.02% 282
2023
Q3
$90.4K Sell
14,458
-800
-5% -$3.47K 0.01% 257
2023
Q2
$66.4K Buy
+15,258
New +$33.9K 0.01% 265
2022
Q1
Sell
-24,250
Closed -$94K 310
2021
Q4
$94K Sell
24,250
-55,150
-69% -$261K 0.02% 257
2021
Q3
$493K Sell
79,400
-7,222
-8% -$61.6K 0.1% 136
2021
Q2
$1.02M Sell
86,622
-72,361
-46% -$833K 0.22% 71
2021
Q1
$2.52M Buy
158,983
+111,493
+235% +$2.01M 0.61% 28
2020
Q4
$310K Buy
+47,490
New +$348K 0.03% 212

Other funds holding LFMD

Magnus Financial Group's LFMD Position: Q2 2026 in Review

Magnus Financial Group held its LifeMD (LFMD) position steady in Q2 2026 at 12,000 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Magnus Financial Group first reported a position in LFMD in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.52M in Q1 2021. 10 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Magnus Financial Group held 12,000 shares of LifeMD worth $49.6K as of Q2 2026.
  • Magnus Financial Group left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up ﹤0.01% of Magnus Financial Group's portfolio in Q2 2026, its #390 holding.
  • Magnus Financial Group first reported a position in LifeMD in Q4 2020 and has held it in 16 quarters since.
  • Magnus Financial Group's LifeMD position peaked at $2.52M in Q1 2021.
  • 10 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.